Citation: R. Anand et al., THERAPEUTIC EFFECTS OF EXELON(TM) IN THE TREATMENT OF PATIENTS WITH ALZHEIMERS-DISEASE, Neurology, 48(3), 1997, pp. 63001-63001
Citation: R. Anand et al., EFFICACY AND SAFETY RESULTS OF THE EARLY PHASE STUDIES WITH EXELON(TM) (ENA-713) IN ALZHEIMERS-DISEASE - AN OVERVIEW, Journal of drug development and clinical practice, 8(2), 1996, pp. 109-116
Citation: R. Anand et G. Gharabawi, CLINICAL DEVELOPMENT OF EXELON(TM) (ENA-713) - THE ADENA(R) PROGRAM, Journal of drug development and clinical practice, 8(2), 1996, pp. 117-122